Trial Profile
Efficacy of bevacizumab and lomustine in patients with glioblastoma: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Lomustine
- Indications Dyspnoea
- Focus Therapeutic Use
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 02 Jun 2017 New trial record